Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-094089
Filing Date
2025-07-03
Accepted
2025-07-03 18:59:42
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7951
  Complete submission text file 0000950170-25-094089.txt   9506
Mailing Address C/O BAY CITY CAPITAL, LLC 750 BATTERY STREET, SUITE 400 SAN FRANCISCO CA 94111
Business Address
Hopfner Robert Lorne (Reporting) CIK: 0001551966 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39397 | Film No.: 251106716

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)